| Apellido | SALMAN |
| Nombre | PAMELA |
| ID | 5949839 |
"Su solicitud se enviará en seg. Por favor espere."
SUGERENCIAS
Salman M, Patricio Autor ID: 6810290 ver autor
Articulos ( 9 en total, se muestran 3 )
● An update on parathyroid carcinoma, 2021
● Consensus statement of the Chilean endocrinological society on the role of bariatric surgery in type 2 diabetes, 2018
● From macro to micro thyroid carcinoma: records of a clinical hospital from 1991 to 2010, 2013
Afiliaciones ( 4 en total, se muestran 3 )
● Escuela de Medicina
● Hospital Clínico Universidad de Chile
● Pontificia Universidad Católica de Chile
Salman B, Pamela Autor ID: 3887902 ver autor
Articulos ( 1 en total )
● Looking for a general response curve to chemotherapy based on radiological evaluation with recist criteria Buscando una curva general de respuesta a la quimioterapia basada en la evaluacion radiologica con criterio recist, 2009
Afiliaciones ( 1 en total )
● Fundación Arturo López Pérez
Salman Boghikian, Pamela Autor ID: 5127653 ver autor
Articulos ( 1 en total )
● Consensus for Treatment of Metastatic Castration-Sensitive Prostate Cancer: Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC), 2021
Afiliaciones ( 1 en total )
● Fdn Arturo Lopez Perez
Salman, P. Autor ID: 8288394 ver autor
Articulos ( 1 en total )
● Association of biomarkers with response to first-line (1L) vibostolimab (anti-TIGIT) coformulated with pembrolizumab (vibo/pembro) in advanced head and neck squamous cell carcinoma (HNSCC): Results from KEYVIBE-005, 2024
Afiliaciones ( 1 en total )
● Oncovida Canc Ctr
Salman, P. Autor ID: 8288460 ver autor
Articulos ( 1 en total )
● Efficacy and safety of darolutamide plus androgen-deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) from the phase III ARANOTE trial, 2024
Afiliaciones ( 1 en total )
● Oncovida Res
Salman, Pamela Autor ID: 8339205 ver autor
Articulos ( 1 en total )
● Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-Cx11/GOG 3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in patients with high-risk locally advanced cervical cancer, 2024
Afiliaciones ( 1 en total )
● Oncovida Canc Ctr
Salman, P. Autor ID: 8348912 ver autor
Articulos ( 1 en total )
● Safety and efficacy of vibostolimab (anti-TIGIT) coformulated with pembrolizumab (vibo/pembro) in previously untreated advanced head and neck squamous cell carcinoma (HNSCC): Results from the phase II KEYVIBE-005 study, 2024
Afiliaciones ( 1 en total )
● Fdn Arturo Lopez Perez
ÁREA DE TRABAJO
FIRMA SELECCIONADA COMO BASE
Salman, Pamela Autor ID: 5949839 ver autor
Articulos ( 45 en total, se muestran 3 )
● A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus, 2023
● A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update, 2013
● Addressing the unmet needs of patients with BRAF-mutated melanoma in Latin America: Expert perspective, 2023
Afiliaciones ( 30 en total, se muestran 3 )
● Austin Hospital
● Azienda Ospedaliera San Camillo Forlanini
● Centro Médico San Roque
FIRMAS SELECCIONADAS PARA AGRUPAR